Protocolo diagnóstico y tratamiento empírico del paciente con infección por el VIH con sintomatología respiratoria
- Arizcorreta Yarza, A.
- Guerrero Sánchez, Francisca M.
- Martín Aspas, Andrés
- López Alonso, B.
ISSN: 0304-5412
Year of publication: 2014
Issue Title: Enfermedades infecciosas (I): infecciones víricas, infección por VIH
Series: 11
Issue: 49
Pages: 2928-2932
Type: Article
More publications in: Medicine: Programa de Formación Médica Continuada Acreditado
Abstract
HIV-associated pulmonary diseases are mainly related with infection. They remain as a major cause of morbidity. Bacterial pneumonia and acute bronchitis are frequent, although Pneumocystis jiroveci pneumonia (PCP) is the most common opportunistic infection in developed countries between patients with poor immune control. The incidence of non-AIDS defining malignancies (lung cancer) has increased. Lung cancer is the leading cause of death among non-AIDS-related neoplasms.
Bibliographic References
- M. Estébanez-Muñoz, C.I. Soto Abánades, J.J. Ríos Blanco, J.R. Arribas Actualización en la patología pulmonar relacionada con la infección por VIH Arch Bronconeumol, 48 (2012), pp. 126-132
- R.J. Boyton Infectious lung complications in patients with HIV/AIDS Curr Opin Pulm Med, 11 (2005), pp. 203-207
- G. Narayanswami, S.H. Salzman Bronchoscopy in the human immunodeficiency virus-infected patient Semin Respir Infect, 18 (2003), pp. 80-86
- G. Madeddu, L.M. Fiori, S. Mura Bacterial community acquired pneumonia in HIV infected patients Curr Opin Pulm Med, 16 (2010), pp. 201-207
- J.E. Kaplan, C. Benson, K.H. Holmes, J.T. Brooks, A. Pau, H. Masur Guidelines for prevention and treatment of opportunistic infections in HIV infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America MMWR Recomm Rep, 58 (2009), pp. 1-198
- P.M. Hauser, J. Bille, C. Lass Flörl, C. Geltner, M. Feldmesser, M. Levi Multicenter, prospective clinical evaluation of respiratory samples from subjects at risk for Pneumocystis jirovecii infection by use of a commercial real time PCR assay J Clin Microbiol., 49 (2011), pp. 1872-1878